A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.
Sportschosun on MSN
For the first time in the world, the effectiveness of acquired hereditary hearing loss treatment has...
A study has confirmed the effectiveness of a drug that can treat acquired genetic hearing loss. On the 11th, a research team led by Professor Ji Heon-young, Professor Jang Seung-hyun of Yonsei ...
The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology ...
The Trump administration made a deal with pharmaceutical giants Eli Lilly and Novo Nordisk to lower prices for blockbuster ...
More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...
Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of ...
WATERTOWN, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Insider claims people have found a way to get around the move BOSSES of the new Harry Potter TV series have hired sniffer dogs over fears of drugs being used on set. They suspect trades-people working ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Researchers from Queen Mary University of London's School of Biological and Behavioral Sciences, using the simple fission yeast as a model, have shown that the new TOR inhibitor rapalink-1 prolongs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback